Capricor Therapeutics
CAPR
#7992
Rank
A$0.43 B
Marketcap
A$9.58
Share price
-4.36%
Change (1 day)
-58.91%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: A$0.43 Billion

As of December 2025 Capricor Therapeutics has a market cap of A$0.43 Billion. This makes Capricor Therapeutics the world's 7992th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.43 B-57.43%
2024A$1.02 B365.71%
2023A$0.22 B54.37%
2022A$0.14 B46.7%
2021A$97.59 M7%
2020A$91.21 M854.42%
2019A$9.55 M-47.68%
2018A$18.26 M-64.89%
2017A$52.03 M-34.11%
2016A$78.96 M15.14%
2015A$68.58 M27.85%
2014A$53.64 M25.97%
2013A$42.58 M2010.25%
2012A$2.01 M-90.44%
2011A$21.1 M-0.15%
2010A$21.13 M-42.06%
2009A$36.48 M25.4%
2008A$29.09 M-80.81%
2007A$0.15 B3857.36%
2006A$3.83 M-42.88%
2005A$6.7 M5.76%
2004A$6.34 M22.42%
2003A$5.18 M-72.39%
2002A$18.76 M

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Capricor Therapeutics was reported to be:

A$2.23 Billion
by Nasdaq info icon info icon
A$0.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Cytokinetics
CYTK
A$11.11 B 2,436.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$65.73 M-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$749.80 B 171,037.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$23.38 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$2.82 B 544.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$15.13 M-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA